DIA

Last chance to register for UK National QPPV Forum on 15 October! This year, we will explore the Windsor Framework and its implications for pharmacovigilance. Get insights directly from the MHRA and engage with industry experts! Here’s what you will gain: ◾ In-depth discussions on the Windsor Framework ◾ Insights from the MHRA ◾ Perspectives from diverse industry representatives ◾ Interactive Q&A sessions to address your questions Don’t miss this opportunity to deepen your understanding and stay updated! Register now: https://bit.ly/46Jh2JE. Lauren East Elspeth McIntosh Louise Woodward Cláudia Ferreira Nicola Lawson Millican Stephanie Deborah Robinson Claire Longman Helen Fiddes Sophie Radicke #Pharmacovigilance #DrugSafety #QPPV #UK #WindsorFramework

The 2024 DIA India Annual Meeting wrapped up last week in Mumbai, India, and we are grateful to everyone who contributed to its success. With over 200 participants in attendance, this year’s event provided a valuable platform for industry leaders, regulators, and healthcare professionals to explore the current and future landscape of healthcare in India. We would like to extend our sincere thanks to all the speakers, programme committee, attendees, DIA members, sponsors, exhibitors, and media partners who contributed to making this meeting a success. This year, we were excited to introduce three specialised tracks, focusing on medical devices, pharmacovigilance, and clinical advancements, which sparked insightful discussions and fostered valuable connections. We also explored key issues such as AI’s role in healthcare, regulatory developments, and strategic collaborations. We look forward to continuing these conversations and shaping the future of healthcare together. Stay tuned for more exciting news! Prof. Moin Don Dr. Ashish Indani Fahd Khan Prashant Joshi Ritu Jaswal Dr Shadab Makhdoomi Dr. Sonica Sachdeva Batra Dr Vijay Venkatraman Janarthanan Vijay Bhargav Swapnali Raut Dr. Pramod Kashid manjusha rajarshi Manish Paliwal omprakash sadhwani Priyadarshini Arambam Susan Korah Dr Ashok Swain Nishank Nivedit Vinita Shetty Karan Haseja Ritu Rathod Ania Mitan Nathalie Preiswerk Karan Solanki #DIAIndia #Pharmacovigilance #Clinical #RegulatoryAffairs #MedicalDevices

The early bird rate ends in just 4 days! Don’t miss out on the chance to enhance your knowledge at the 'Medical Devices and Drug-Device Combination Products Workshop: Post-Market Surveillance and Clinical Evidence' from 2 to 4 December. Join renowned experts and learn about PMS systems, risk analysis, and clinical evaluation. Register now and stay ahead in the evolving medical devices landscape: https://bit.ly/3XTY7tq. #DIALearning #TrainingCourse #MedicalDevices #CombinationProducts #PMS 

Natural history studies using RWD include data collection intervals based on real-world medical treatment patterns and will not necessarily align with clinical trial visit intervals, thereby requiring methodology and potentially imputation to make direct comparisons to trial data. More real-world content is coming this season! DIA is offering an in-person Real-World Evidence Conference & two virtual learning opportunities this month. Explore Opportunities ➡ https://ow.ly/8WA350TApT6

Achieving Excellence in Regulatory Information Management eBook📖 Get your copy now and receive insights on best practices and technologies to improve the way regulatory works. Purchase now at https://ow.ly/tvk350TzuC6

The Medical Information and Communications Conference successfully concluded last week and we would like to extend our sincere thanks to everyone who contributed to its success — participants, speakers, programme committee, exhibitors, and DIA members. With over 100 participants, this year’s conference provided a platform for rich discussions on the evolving MedInfo landscape. From insightful sessions on AI advancements and real-world evidence to practical strategies for enhancing customer experiences, the range of topics covered was truly remarkable! It was inspiring to see so many professionals come together to explore how we can continue to improve medical information, particularly in today’s rapidly changing digital environment. A key highlight of the conference was the Open Mic session, which provided an inclusive platform for open dialogue and the exchange of innovative ideas. In addition, the Networking Dinner offered a valuable opportunity for colleagues to connect and build meaningful relationships beyond the formal sessions. Once again, we extend our heartfelt thanks to everyone who made this conference such a success. Stay tuned for more exciting updates! Elvar M. Eyjolfsson Hakan Aribas, MD. Dr Isabelle Widmer (MD) Jürgen W.G. B. Katia Castrillo, PhD Marie-Luise Helmich Michelle Bridenbaker Peter Brodbin Sarah Dunnett Cláudia Ferreira #MedInfo24 #MedicalInformation #MedicalCommunication #Conference

Join Sara Torgal (DIA), Bandar Alhammad (SFDA), Ahmed Babiker (Ministry of Public Health of Qatar) and Amira Younes (MSD) for the 2024 DIA Middle East & North Africa (MENA) Conference this November. This is your chance to connect with health authorities, industry experts, and key stakeholders from across the region. At the conference, you will collaborate on shaping the future of regulatory frameworks, network with over 300 professionals from diverse countries, and discover cutting-edge strategies for advancing medicinal product development. Don't miss out — the early bird and group rates are ending on 1 October. Secure your spot today: https://bit.ly/3X4ghrA. #DIAMENA2024 #Collaboration #LifeSciences #RegulatoryAffairs

We're #hiring a new Event Coordinator in Tokyo. Apply today or share this post with your network.

Don't miss your final opportunity to join our in-depth pharmacovigilance training from 8 to 11 October. This face-to-face course, co-organised with the Dutch Medicines Evaluation Board (MEB), covers all essential pharmacovigilance processes outlined in GVP modules I to XVI. Gain a solid foundation in European post-marketing safety regulations, stay updated on the latest pharmacovigilance legislation, and learn about ICH activities. Enhance your pharmacovigilance knowledge and network with regulators and industry experts! Hear from one of the Programme Committee members, Wendy Huisman, Director of Vigifit, why you can't afford to miss this course! Secure your spot today: https://bit.ly/3WU0Z93. #Pharmacovigilance #DrugSafety #Learning #GVP

So proud of the work we’re doing together with our members, our industry, our regulators, our patients, and our teammates all around the globe. Our team is here to help you help advance care for patients everywhere.